- Home
- SIDU vs ANTX Comparison
SIDU vs ANTX Comparison
Compare SIDU & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- ANTX
- Stock Information
- Founded
- SIDU 2012
- ANTX 2017
- Country
- SIDU United States
- ANTX United States
- Employees
- SIDU 82
- ANTX N/A
- Industry
- SIDU Telecommunications Equipment
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- ANTX Health Care
- Exchange
- SIDU Nasdaq
- ANTX Nasdaq
- Market Cap
- SIDU 34.5M
- ANTX 37.6M
- IPO Year
- SIDU 2021
- ANTX 2022
- Fundamental
- Price
- SIDU $2.40
- ANTX $1.13
- Analyst Decision
- SIDU Strong Buy
- ANTX Hold
- Analyst Count
- SIDU 1
- ANTX 5
- Target Price
- SIDU $10.00
- ANTX $3.50
- AVG Volume (30 Days)
- SIDU 1.1M
- ANTX 134.2K
- Earning Date
- SIDU 03-25-2025
- ANTX 03-27-2025
- Dividend Yield
- SIDU N/A
- ANTX N/A
- EPS Growth
- SIDU N/A
- ANTX N/A
- EPS
- SIDU N/A
- ANTX N/A
- Revenue
- SIDU $5,189,912.00
- ANTX N/A
- Revenue This Year
- SIDU $36.85
- ANTX N/A
- Revenue Next Year
- SIDU $40.00
- ANTX N/A
- P/E Ratio
- SIDU N/A
- ANTX N/A
- Revenue Growth
- SIDU N/A
- ANTX N/A
- 52 Week Low
- SIDU $1.15
- ANTX $0.87
- 52 Week High
- SIDU $10.15
- ANTX $3.88
- Technical
- Relative Strength Index (RSI)
- SIDU 42.76
- ANTX 44.20
- Support Level
- SIDU $2.56
- ANTX $1.09
- Resistance Level
- SIDU $2.75
- ANTX $1.20
- Average True Range (ATR)
- SIDU 0.22
- ANTX 0.05
- MACD
- SIDU -0.00
- ANTX 0.01
- Stochastic Oscillator
- SIDU 22.08
- ANTX 52.98
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.